Toggle light / dark theme

Sensors are usually thought of in terms of physical devices that receive and respond to electromagnetic signals – from everyday sensors in our smartphones and connected home appliances to more advanced sensors in buildings, cars, airplanes and spacecraft. No physical sensor or aggregation of electronic sensors, however, can continuously and globally detect disturbances that take place on or above the earth’s surface. But the physical atmosphere itself may offer such a sensing capability, if it can be understood and tapped into.

To that end, DARPA recently announced its Atmosphere as a Sensor (AtmoSense) program, whose goal is to understand the fundamentals of energy propagation from the ground to the ionosphere to determine if the atmosphere can be used as a sensor. A Proposers Day is scheduled for February 14, 2020, in Arlington, Virginia.

It’s well known that energy propagates from the Earth’s surface to the ionosphere, but the specifics of how that happens is not currently known enough to use the atmosphere as a sensor. Scientific literature has clearly documented that events like thunderstorms, tornadoes, volcanos, and tsunamis make big “three-dimensional wakes” that propagate to the upper reaches of the ionosphere and leave a mark there. Since that energy traverses several other layers of atmosphere – the troposphere, stratosphere, and mesosphere – on its way up to the ionosphere, the idea is to try and identify the disturbances the “wake” is making along its way to see if researchers can capture information to indicate what type of event caused it.

French health officials declared an end to the country’s COVID-19 outbreak on Monday.

France had confirmed 12 cases of the coronavirus since it first reached the country on January 24. Unfortunately, one of those patients died from their infection. But the French-language news outlet Le Parisien reports that the remaining 11 have all made complete recoveries — meaning there are no longer any COVID-19 cases in any French hospital.

There are “no longer any hospitalized patients in France,” said Health Minister Olivier Véran, in French. “The last one is cured and is no longer contagious.”

Because the concept of smart cities is still very new, with rare finalized and implemented projects, the topic is still unclear. Although big titles and strategies are well defined, the on-ground application is still uncertain, giving us the opportunity to question its planning process. In fact, how can we go wrong when designing smart cities? What key element are we failing to address in the planning phase?

The answer is quite simple. While a lot of city leaders try to skip crucial planning phases to buy time and save money, they often tend to do so by reducing community involvement. Gathering data and implicating every citizen in order to expose the glitches and the needs of society is usually an extensive process. In fact, they would rather adopt basic technologies and generic master plans, than questioning the problems faced by citizens and generating a solution-based design. Governmental officials would prioritize tech over people and not the other way around. Evolving into common practice, many bureaucrats praise a bottom-up approach, but wouldn’t reach out to the less fortunate and the most marginalized part of the society.

How to Future-Proof Our Cities? 4 Key Initiatives to Increase Resilience.

Diabetes is characterized by trouble producing or managing insulin, and one emerging treatment involves converting stem cells into beta cells that secrete the hormone. Now, scientists have developed a more efficient method of doing just that, and found that implanting these cells in diabetic mice functionally cured them of the disease.

The study builds on past research by the same team, led by Jeffrey Millman at Washington University. The researchers have previously shown that infusing mice with these cells works to treat diabetes, but the new work has had even more impressive results.

“These mice had very severe diabetes with blood sugar readings of more than 500 milligrams per deciliter of blood — levels that could be fatal for a person — and when we gave the mice the insulin-secreting cells, within two weeks their blood glucose levels had returned to normal and stayed that way for many months,” says Millman.